As of 2025-07-11, the Relative Valuation of Surmodics Inc (SRDX) is (48.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.02 USD, the upside of Surmodics Inc based on Relative Valuation is -257.3%.
The range of the Relative Valuation is (46.73) - (48.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.0x - 38.6x | 35.8x |
| Forward P/E multiples | 33.6x - 34.7x | 34.4x |
| Fair Price | (46.73) - (48.23) | (48.79) |
| Upside | -250.6% - -255.5% | -257.3% |
| Date | P/E |
| 2025-07-10 | -22.33 |
| 2025-07-09 | -22.20 |
| 2025-07-08 | -21.61 |
| 2025-07-07 | -21.35 |
| 2025-07-03 | -21.59 |
| 2025-07-02 | -20.88 |
| 2025-07-01 | -21.08 |
| 2025-06-30 | -21.39 |
| 2025-06-27 | -20.74 |
| 2025-06-26 | -20.94 |
| 2025-06-25 | -20.81 |
| 2025-06-24 | -20.89 |
| 2025-06-23 | -20.88 |
| 2025-06-20 | -20.88 |
| 2025-06-18 | -20.98 |
| 2025-06-17 | -20.91 |
| 2025-06-16 | -21.50 |
| 2025-06-13 | -20.99 |
| 2025-06-12 | -20.94 |
| 2025-06-11 | -20.87 |
| 2025-06-10 | -21.02 |
| 2025-06-09 | -20.99 |
| 2025-06-06 | -21.17 |
| 2025-06-05 | -21.45 |
| 2025-06-04 | -21.59 |
| 2025-06-03 | -21.24 |
| 2025-06-02 | -21.22 |
| 2025-05-30 | -20.89 |
| 2025-05-29 | -21.26 |
| 2025-05-28 | -21.02 |
| 2025-05-27 | -20.74 |
| 2025-05-23 | -20.66 |
| 2025-05-22 | -20.99 |
| 2025-05-21 | -20.95 |
| 2025-05-20 | -21.37 |
| 2025-05-19 | -21.22 |
| 2025-05-16 | -20.58 |
| 2025-05-15 | -20.18 |
| 2025-05-14 | -20.11 |
| 2025-05-13 | -20.03 |
| 2025-05-12 | -19.50 |
| 2025-05-09 | -19.27 |
| 2025-05-08 | -19.59 |
| 2025-05-07 | -19.55 |
| 2025-05-06 | -19.70 |
| 2025-05-05 | -19.42 |
| 2025-05-02 | -19.90 |
| 2025-05-01 | -20.06 |
| 2025-04-30 | -20.17 |
| 2025-04-29 | -22.27 |